Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Share News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 19.00
Ask: 20.00
Change: 0.00 (0.00%)
Spread: 1.00 (5.263%)
Open: 19.50
High: 19.50
Low: 19.50
Prev. Close: 19.50
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: M&C Saatchi pulls Next Fifteen deal support

Fri, 17th Jun 2022 10:46

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Directa Plus PLC, up 10% at 107.00 pence, 12-month range 95.1p-178p. Sees an acceleration in trading in the last two months since the first quarter of the year. The graphene-based product supplier says that revenue from the start of the year to the end of May was approximately 44% ahead of the same period the previous year at EUR4.6 million. Directa Plus says this was driven by growth in all its commercial verticals, with sales in line with expectations.

----------

Bidstack Group PLC, up 6.4% at 2.40p, 12-month range 1.6p-6.15p. The in-game advertising platform hires David Reeves as chair designate to succeed Donald Stewart on September 1. The company says Reeves will serve as a non-executive director in the meantime. Stewart will move to a non-executive role and serve on the audit and remuneration Committees on Reeves' becoming the chair. Reeves has over 30 years' global experience in senior management roles within multinational companies across the video games industry, having working at Sony and Capcom.

----------

AIM - LOSERS

----------

ValiRx PLC, down 12% at 19.15p, 12-month range 17.3p-63p. The drug development company anticipates extension request to the exclusivity period between itself and TheroemRx Inc regarding the proposed sub-licence for VAL201. An exclusivity period was granted to June 30 to enable TheoremRx to progress its financing round, which the sub-licence of VAL201 depends. Progress on financing remains positive, but ValiRx anticipates that an extension to the exclusivity period will be requested and intends to seek "more formal confirmation" of the progress. "The letter of intent and proposed sub-license therefore remain non-binding and there is no guarantee that this sub-license will be executed or that it will generate material revenues within the expected timeframe or at all," it says.

----------

M&C Saatchi PLC, down 7.3% at 164p, 12-month range 122p-227p. Directors pull support for takeover offer by Next Fifteen Communications Group PLC, while still not supporting a rival offer by AdvancedAdvT Ltd. M&C Saatchi directors "no longer consider the terms of the Next 15 offer to be fair and reasonable solely on the basis of the deterioration in value of Next 15 shares since the announcement date," the London-based advertising agency explains. Since announcing its share-based acquisition offer in May, Next Fifteen shares have fallen by around 30%. M&C Saatchi, however, also warns that it may be prevented from delivering on its own plans as a standalone company. Shares in Next Fifteen fall 1.9% on Friday.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
2 Aug 2021 15:14

IN BRIEF: Directa Plus Italy arm inks coronavirus recovery loans

IN BRIEF: Directa Plus Italy arm inks coronavirus recovery loans

Read more
2 Aug 2021 13:11

Directa Plus qualifies for Italian government loans

(Sharecast News) - Graphene nanoplatelet technology company Directa Plus has qualified for a total of €0.7m in loans under the Italian government's Covid-19 recovery plan, it announced on Monday.

Read more
28 Jul 2021 18:07

TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident

TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident

Read more
23 Jun 2021 17:25

TRADING UPDATES: Marlowe turns to loss; AFC Energy sees maiden revenue

TRADING UPDATES: Marlowe turns to loss; AFC Energy sees maiden revenue

Read more
23 Jun 2021 10:43

Strong trading continues through first half at Directa Plus

(Sharecast News) - Graphene nanoplatelet technology company Directa Plus said on Wednesday that the strong trading it had seen in the first four months of the financial year had continued through the rest of the half-year, with trading in line with market expectations.

Read more
16 Jun 2021 15:58

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
7 Jun 2021 10:44

Directa Plus customer eyes production in Europe using graphene product

Directa Plus customer eyes production in Europe using graphene product

Read more
7 Jun 2021 10:38

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

Read more
17 May 2021 12:11

TRADING UPDATES: Hollywood Bowl sees risk of 4th lockdown in December

TRADING UPDATES: Hollywood Bowl sees risk of 4th lockdown in December

Read more
5 May 2021 19:20

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

Read more
19 Apr 2021 18:01

TRADING UPDATES: Mattioli buys Caledonia; Arbuthnot lowers STB stake

TRADING UPDATES: Mattioli buys Caledonia; Arbuthnot lowers STB stake

Read more
9 Apr 2021 13:44

EXECUTIVE CHANGES: Melrose Industries adds two non-executives to board

EXECUTIVE CHANGES: Melrose Industries adds two non-executives to board

Read more
29 Mar 2021 20:22

IN BRIEF: Directa Plus gets EU-wide patent for graphene in golf balls

IN BRIEF: Directa Plus gets EU-wide patent for graphene in golf balls

Read more
18 Mar 2021 14:58

TRADING UPDATES: Mobile Streams revenue surges in first quarter

TRADING UPDATES: Mobile Streams revenue surges in first quarter

Read more
18 Mar 2021 09:30

Directa Plus reports 'strong' Q1 trading performance

(Sharecast News) - Graphene nanoplatelets producer Directa Plus said on Thursday that first-quarter trading had been "strong", with revenues projected to show a marked improvement year-on-year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.